Displaying items by tag: scientists
DULUTH, Ga., Aug. 6, 2021 /PRNewswire/ -- Nearly 900 veterinary students and leaders from three dozen veterinary schools in the U.S. convened virtually this week for the annual National Veterinary Scholars Symposium. They learned from researchers, public health officials and industry experts about the global burden of disease, infectious disease control and potential pathways for research careers – such as in emerging and transboundary diseases – where their veterinary training and One Health perspective is critical.
In addition, several students were recognized with Boehringer Ingelheim Research Awards for Graduate Veterinarians and Veterinary Students. Winning students receive monetary prizes and a stipend to attend the Symposium to accept their awards and present their research.
Dr. Brittany Szafran, from Mississippi State's College of Veterinary Medicine, received the 2021 Boehringer Ingelheim Veterinary Research Award for Graduate Veterinarians, which promotes research in veterinary biosciences. It recognizes graduate veterinarians who have completed or will soon complete a Ph.D. program or are in their final years of residency training in veterinary pathology, medicine, surgery, radiology/ imaging, or laboratory animal medicine. Dr Szafran's work has focused on the underlying biochemical and immunologic mechanisms in response to pesticides to better understand and help protect the health of people, animals, and the environment from the potential toxicity of chemicals.
Carley Allen, from the University of Missouri College of Veterinary Medicine, received the 2021 Boehringer Ingelheim Veterinary Research Award for Veterinary Students. Allen's research has focused on investigating a novel molecular target for inhibiting cell growth and improving survival in canine osteosarcoma, the most common skeletal malignancy of dogs and a beneficial comparative and translational model for human osteosarcoma.
Brittany Allen, from Ohio State University's College of Veterinary Medicine, and Jaqueline Chevalier, from Cornell University's College of Veterinary Medicine, also received recognition as honorable mention Boehringer Ingelheim Veterinary Research Scholars.
The annual National Veterinary Scholars Symposium was hosted this year by Iowa State University's College of Veterinary Medicine, and sponsored by Boehringer Ingelheim, the American Association of Veterinary Medical Colleges, the American Veterinary Medical Association and the National Institutes of Health. The symposium showcases research conducted by veterinary students in the course of their Veterinary Scholar Program research internships.
"These students are joining the life sciences field at a remarkable time. The frequency of pandemics and transboundary threats is predicted to increase, presenting new and greater risks to human and animal health, as well as our food supply," Caroline Belmont, head of U.S. Animal Health Innovation for Boehringer Ingelheim, said in a welcome address to participants. "The One Health perspectives and capabilities of today's veterinary students will undoubtedly play a critical role in addressing our future challenges, and the hands-on experience, guidance and support we provide them now represents an important investment in the future health of animals and humans."
The Boehringer Ingelheim Veterinary Scholars Program was established more than 30 years ago to introduce first- and second-year veterinary medical students to biomedical research. At each participating school, Boehringer Ingelheim Veterinary Scholars are assigned a mentor and laboratory. Each scholar conducts a hypothesis-driven research project. The research project is typically conducted over a 10-12-week period during the summer, with students presenting their work at the conclusion. Nearly 5,000 students have received stipends from Boehringer Ingelheim to conduct research since the program started. More information is available at http://veterinaryscholars.boehringer-ingelheim.com/.
Boehringer Ingelheim Animal Health
The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Across the globe, our 9,700 employees are dedicated to delivering value through innovation, thus enhancing the well-being of both.
Respect for animals, humans and the environment guides us every day. We develop solutions and provide services to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society-threatening diseases.
Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of $4.7 billion (4.1 billion euros) in 2020 and presence in more than 150 countries.
Boehringer Ingelheim Animal Health has a significant presence in the United States, with more than 3,100 employees in places that include Georgia, Missouri, Iowa, Minnesota, New Jersey and Puerto Rico. To learn more, visit www.boehringer-ingelheim.us, www.facebook.com/BoehringerAHUS or www.twitter.com/Boehringer_AH.
Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim has been independent and family owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.
As a world-leading, research-driven pharmaceutical company, with around 52,000 employees, we create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
In 2020, Boehringer Ingelheim achieved net sales of around $22.33 billion (19.57 billion euros). Our significant investment of over $4.2 billion (3.7 billion euros) in 2020 (18.9% of net sales) in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.
We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.
Movie Review written by Jon Patch with 3 out of 4 paws
The Tomorrow War
New Republic Pictures, Amazon Studios and Skydance Media present a PG-13, 140-minute, Action, Adventure, Sci-Fi. Drama directed by Chris McKay and written by Zach Dean and streaming now.
RALEIGH, NC (November 5, 2019) – The AKC Canine Health Foundation (CHF) announces another year of growth in grants awarded for canine health research. In 2019, CHF has awarded 46 new research grants totaling over $2.8 million to benefit canine health. CHF currently manages 135 active grants representing funding of more than $10.8 million, bringing their total funding to $52.9 million for canine health research and educational programs. Outcomes from this funding have resulted in more than 775 publications in peer-reviewed journals since their founding in 1995.In addition to addressing overall health concerns for all dogs, CHF’s ongoing hemangiosarcoma, tick-borne disease, and epilepsy research initiatives provided expanded funding opportunities for these important diseases during 2019. CHF and their donors continued funding for new educational grants to support the American Kennel Club/AKC Canine Health Foundation/Theriogenology Foundation Small Animal Theriogenology Residency Program, and their Clinician-Scientist Fellowship Program.As part of the educational outreach component of their mission, CHF sponsored five webinars by CHF-funded investigators on topics such as CBD oil use for dogs, updates on canine influenza, canine degenerative myelopathy, early maternal influences on puppies being raised as service dogs, and discussion of spay/neuter on overall health, providing continuing education for veterinary professionals, dog owners, and breeders. Also, CHF hosted the National Parent Club Canine Health Conference in St. Louis, MO in August. The biennial event, sponsored by Purina, brought together researchers, American Kennel Club (AKC) Parent Club members, breeders, veterinarians, veterinary residents, and veterinary students to discuss the latest findings in canine health research.“We are honored to collaborate with the best scientists, breeders, veterinarians and dog lovers to achieve better health for all dogs,” states CHF CEO, Dr. Diane Brown. “As we enter our 25th year in 2020, we look forward to creating more opportunities to advance canine health research."CHF earned a highest four-star rating from Charity Navigator again this year and maintained its platinum rating from GuideStar, demonstrating programs excellence and that it exceeds industry standards for fiscal responsibility, accountability and transparency, and outperforms most charities in its category.Matched funding opportunities provided a means for CHF donors to double their impact on canine health in 2019. The AKC continues to match donations from new and lapsed donors and the American German Shepherd Dog Charitable Foundation is matching donations for hemangiosarcoma research.With gratitude for their donors’ support, CHF continues to achieve its mission to advance the health of all dogs and their owners by funding humane scientific research and supporting the dissemination of health information to prevent, treat and cure canine disease. Donation information can be found at akcchf.org/donate.
# # #
Since 1995, the AKC Canine Health Foundation has leveraged the power of science to address the health needs of all dogs. With more than $52 million in funding to date, the Foundation provides grants for the highest quality canine health research and shares information on the discoveries that help prevent, treat and cure canine diseases. The Foundation meets and exceeds industry standards for fiscal responsibility, as demonstrated by their highest four-star Charity Navigator rating and GuideStar Platinum Seal of Transparency. Learn more at www.akcchf.org.
Panthera Launches Epic ‘Journey of the Jaguar’ Expedition to Secure a Future for the Americas' Largest Wild Cat
World’s foremost jaguar scientists make first-ever attempt to traverse, protect the Jaguar Corridor in three-year, ten nation odyssey across Latin America
July 24, 2017
New York, NY – Panthera, the only organization dedicated to conserving the world’s 40 wild cat species, today launched the Journey of the Jaguar – a three-year, ten-nation odyssey from Mexico to Argentina that seeks to secure a future for the Americas’ largest wild cat.
Sixteen years after first identifying the Jaguar Corridor, Panthera CEO Dr. Alan Rabinowitz, accompanied by Jaguar Program Executive Director Dr. Howard Quigley, will lead the first-ever attempt by man to traverse this six million km2 landscape with the singular mission of accelerating progress to protect it. With Panthera’s scientists and partners, they will assess the state of the jaguar, the integrity of its wild landscapes, and the areas most in need of conservation attention throughout its range.
Shining a light on the importance of the jaguar to ecosystems, economies, and cultures across its range, Drs. Rabinowitz and Quigley will traverse Latin America’s wild landscapes in a race against time to move governments, corporations and communities to take decisive steps to save the jaguar and the incredible diversity of plants and animals, including people, that depend on its survival.
Panthera CEO Dr. Rabinowitz stated, “The Jaguar Corridor exists today because the jaguar shaped it and owned it, overcoming all obstacles that stood in its way. Although human beings are relative latecomers to the story of the jaguar, they are the crucial determinant in what comes next for the species.”
Embarking this week on the first official expedition of the Journey of the Jaguar, Drs. Rabinowitz and Quigley have joined Northern South America Jaguar Program Director, Dr. Esteban Payán, in northern Colombia to explore the nearly impassable Darien gap where Colombia meets Panama; conservation challenges and opportunities that exist in Urabá, home to Colombia’s mangrove saltwater-dwelling jaguars; and the San Lucas Forest, the critical link connecting jaguars in Central and South America.
Stopping off at Panthera’s conflict mitigation model ranches, the team will also visit the site where Panthera captured the first ever photos of a wild jaguar with cubs in an oil palm plantation, underscoring the significance of building sustainable agricultural plots that minimize impacts on migrating wildlife.
Creating refugees out of wild cats, habitat loss and fragmentation caused by human developments like oil palm monocultures is one of the greatest threats facing jaguars, alongside killings in retaliation for livestock depredation and overhunting of prey species. Panthera’s Jaguar Corridor Initiative seeks to connect and protect the mosaic of human-dominated landscapes from Mexico to Argentina that are vital to maintaining the genetic diversity and survival of the species. Cupped between Panama to the north and a handful of South American countries, Colombia holds the key to the jaguar’s passage from Central America to South America.
Dr. Payán stated, “The launch of the Journey of the Jaguar in Colombia is critically timed, as the country embarks on a new era of peace. As formerly unoccupied territories open up for conservation and ecotourism development, Colombia holds outstanding potential to further unify the nation and its people with a new focus on building peace with biodiversity. Protecting Colombia’s tremendous wild places and wildlife, including jaguars, is part and parcel of protecting the future of the people of Colombia.”
Just in time for the latest expedition, Panthera today launched a new, interactive Journey of the Jaguar website, allowing users to follow Panthera’s jaguar scientists in real-time, and showcasing the fascinating stories, photos, and videos of the people, wildlife and landscapes the team encounters along the way.
Timed with the launch of a new conservation program in Mexico earlier this year, the first Journey of the Jaguar expedition explored Mexico’s Yucatán Peninsula, home to part of the country’s largest jaguar population. In April, Panthera’s scientists embarked on the second journey, traveling on foot and by mule from southeastern Arizona into Sonora and Sinaloa to assess the Northern Corridor’s unique threats and greatest conservation needs.
Dr. Quigley stated, “Securing the future of the jaguar has been a lifelong mission of mine as a scientist, and I’m excited to continue this adventure through the launch of the Journey of the Jaguar. As the survival of many big cats and other wildlife around the globe grows ever more tenuous, with faith in their future burning out, I’m encouraged by the resilience of the jaguar - a big cat for which hope still shines bright.”
Visit journeyofthejaguar.org to learn more.
Panthera, founded in 2006, is devoted exclusively to preserving wild cats and their critical role in the world’s ecosystems. Panthera’s team of leading biologists, law enforcement experts and wild cat advocates develop innovative strategies based on the best available science to protect cheetahs, jaguars, leopards, lions, pumas, snow leopards and tigers and their vast landscapes. In 36 countries around the world, Panthera works with a wide variety of stakeholders to reduce or eliminate the most pressing threats to wild cats—securing their future, and ours. Visit Panthera.org
About the Jaguar Corridor Initiative
Panthera’s Jaguar Corridor Initiative is the only conservation program to date which seeks to protect jaguars across their entire six million km2 range. In partnership with governments, corporations and local communities, Panthera’s Jaguar Corridor Initiative is working to preserve the genetic integrity of the jaguar by connecting and protecting core jaguar populations in human landscapes from northern Mexico to northern Argentina. Learn more.